Indomethacin for prevention of heterotopic ossification after hip arthroplasty - A randomized comparison between 4 and 8 days of treatment

被引：27

作者：

Dorn, U ^{[1
]}

Grethen, C ^{[1
]}

Effenberger, H ^{[1
]}

Berka, H ^{[1
]}

Ramsauer, T ^{[1
]}

Drekonja, T ^{[1
]}

机构：

[1] Salzburg Gen Hosp, Dept Orthoped, A-5020 Salzburg, Austria

来源：

ACTA ORTHOPAEDICA SCANDINAVICA | 1998年 / 69卷 / 02期

关键词：

D O I：

10.3109/17453679809117607

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

In a randomized, parallel group study, we evaluated the efficacy of a 4-day versus an 8-day course of indomethacin (50 mg, 3 times per day), given as prophylaxis against heterotopic ossification after cementless total hip arthroplasty in 209 patients with arthrosis. Patients receiving the prophylaxis for 8 days had less (p = 0.03) severe heterotopic bone formation.

引用

页码：107 / 110

页数：4

共 35 条

[31] THE USE OF INDOMETHACIN TO PREVENT THE FORMATION OF HETEROTOPIC BONE AFTER TOTAL HIP-REPLACEMENT - A RANDOMIZED, DOUBLE-BLIND CLINICAL-TRIAL [J].

SCHMIDT, SA ;

KJAERSGAARDANDERSEN, P ;

PEDERSEN, NW ;

KRISTENSEN, SS ;

PEDERSEN, P ;

NIELSEN, JB .

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1988, 70A (06) :834-838

[32]

SOBALLE K, 1988, CLIN ORTHOP RELAT R, V228, P57

[33]

TORNKVIST H, 1985, CLIN ORTHOP RELAT R, P264

[34] HETEROTOPIC BONE-FORMATION PREVENTED BY DICLOFENAC - PROSPECTIVE-STUDY OF 100 HIP ARTHROPLASTIES [J].

WAHLSTROM, O ;

RISTO, O ;

DJERF, K ;

HAMMERBY, S .

ACTA ORTHOPAEDICA SCANDINAVICA, 1991, 62 (05) :419-421

[35]

WURNIG C, 1992, ACTA ORTHOP SCAND, V63, P628

← 1 2 3 4 →